CXCR3 in T cell function

JR Groom, AD Luster - Experimental cell research, 2011 - Elsevier
CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an
important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells …

CXCR3 ligands: redundant, collaborative and antagonistic functions

JR Groom, AD Luster - Immunology and cell biology, 2011 - Wiley Online Library
CXCR3 is a chemokine receptor that is rapidly induced on naïve T cells following activation,
and preferentially remains highly expressed on type‐1 helper (Th1)‐type CD4+ T cells …

Inflammatory markers in systemic lupus erythematosus

M Aringer - Journal of autoimmunity, 2020 - Elsevier
While systemic lupus erythematosus (SLE) is an autoantibody and immune complex disease
by nature, most of its organ manifestations are in fact inflammatory. SLE activity scores thus …

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus

H Idborg, S Eketjäll, S Pettersson… - Lupus Science & …, 2018 - lupus.bmj.com
Objectives Composite criteria/indices are presently used to diagnose and monitor patients
with systemic lupus erythematosus (SLE). Biomarkers for these purposes would be helpful in …

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

T Rose, A Grützkau, H Hirseland, D Huscher… - Annals of the …, 2013 - ard.bmj.com
Objectives To evaluate and compare the clinical efficacy of three biomarkers for interferon
(IFN) activity (measured directly and indirectly) and six traditional biomarkers in indicating …

CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases–associated …

M Kameda, M Otsuka, H Chiba, K Kuronuma… - PLoS one, 2020 - journals.plos.org
Introduction Interstitial lung disease (ILD) is a heterogeneous group of diseases
characterized by varying degrees of lung inflammation and/or fibrosis. We investigated …

Multi–cell type gene coexpression network analysis reveals coordinated interferon response and cross–cell type correlations in systemic lupus erythematosus

B Panwar, BJ Schmiedel, S Liang, B White… - Genome …, 2021 - genome.cshlp.org
Systemic lupus erythematosus (SLE) is an incurable autoimmune disease disproportionately
affecting women. A major obstacle in finding targeted therapies for SLE is its remarkable …

C1q deficiency leads to the defective suppression of IFN-α in response to nucleoprotein containing immune complexes

DM Santer, BE Hall, TC George… - The Journal of …, 2010 - journals.aai.org
Almost all humans with homozygous deficiency of C1q develop systemic lupus
erythematosus (SLE). The precise cellular mechanism (s) by which C1q prevents the …

[HTML][HTML] Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus

FR Spinelli, R Berti, G Farina, F Ceccarelli, F Conti… - Autoimmunity …, 2023 - Elsevier
Abstract Systemic Lupus Erythematosus (SLE) is a multisystemic autoimmune disorder
characterized by flares-ups/remissions with a complex clinical picture related to disease …

Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus

JA Reynolds, S Haque, K Williamson, DW Ray… - Scientific Reports, 2016 - nature.com
Patients with systemic lupus erythematosus (SLE) have accelerated cardiovascular disease
and dysfunctional endothelial repair mechanisms. Myeloid angiogenic cells (MACs), derived …